P.A.W. Capital Corp C4 Therapeutics, Inc. Transaction History

P.A.W. Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$29.39 - $46.86 $1.18 Million - $1.87 Million	-40,000 Closed	0 $0
Q3 2021 Oct 25, 2021	SELL	$35.91 - $50.5 $359,099 - $505,000	-10,000 Reduced 20.0%	40,000 $1.79 Million
Q1 2021 May 10, 2021	BUY	$31.96 - $46.5 $319,600 - $465,000	10,000 Added 25.0%	50,000 $1.85 Million
Q4 2020 Feb 11, 2021	BUY	$22.8 - $37.05 $912,000 - $1.48 Million	40,000 New	40,000 $1.33 Million

126

63M

651K

115K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $146M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

Stay updated on P.A.W. Capital Corp with notifications on news.